Management of paraneoplastic syndromes in lung cancer.
Curr Treat Options Oncol. 2004 Feb; 5(1):51-62.CT

Abstract

Paraneoplastic syndromes are common complications of lung cancer. Although most frequently associated with advanced disease, paraneoplastic syndromes may also occur at early stages. Occasionally, the paraneoplastic syndrome may be the presenting symptom of lung cancer. For most paraneoplastic syndromes, the best treatment is to treat the underlying malignancy. However, in many cases, treatment of moderate efficacy or urgent therapy is required. Specific recommendations for the management of the most common paraneoplastic syndromes, including cachexia, hypercalcemia, and hyponatremia, are provided.

Authors+Show Affiliations

Thomas L

Division of Hematology-Oncology, Greenebaum Cancer Center, University of Maryland Medical Center, 22 South Greene Street, Baltimore, MD 21201, USA.

Kwok Y

No affiliation info available

Edelman MJ

No affiliation info available

MeSH

HumansLung NeoplasmsNeoplasm StagingParaneoplastic Syndromes

Pub Type(s)

Journal Article

Review

Language

eng

PubMed ID

14697157

Citation

Thomas, Leno, et al. "Management of Paraneoplastic Syndromes in Lung Cancer." Current Treatment Options in Oncology, vol. 5, no. 1, 2004, pp. 51-62.

Thomas L, Kwok Y, Edelman MJ. Management of paraneoplastic syndromes in lung cancer. Curr Treat Options Oncol. 2004;5(1):51-62.

Thomas, L., Kwok, Y., & Edelman, M. J. (2004). Management of paraneoplastic syndromes in lung cancer. Current Treatment Options in Oncology, 5(1), 51-62.

Thomas L, Kwok Y, Edelman MJ. Management of Paraneoplastic Syndromes in Lung Cancer. Curr Treat Options Oncol. 2004;5(1):51-62. PubMed PMID: 14697157.

* Article titles in AMA citation format should be in sentence-case

TY - JOUR T1 - Management of paraneoplastic syndromes in lung cancer. AU - Thomas,Leno, AU - Kwok,Young, AU - Edelman,Martin J, PY - 2003/12/31/pubmed PY - 2004/3/16/medline PY - 2003/12/31/entrez SP - 51 EP - 62 JF - Current treatment options in oncology JO - Curr Treat Options Oncol VL - 5 IS - 1 N2 - Paraneoplastic syndromes are common complications of lung cancer. Although most frequently associated with advanced disease, paraneoplastic syndromes may also occur at early stages. Occasionally, the paraneoplastic syndrome may be the presenting symptom of lung cancer. For most paraneoplastic syndromes, the best treatment is to treat the underlying malignancy. However, in many cases, treatment of moderate efficacy or urgent therapy is required. Specific recommendations for the management of the most common paraneoplastic syndromes, including cachexia, hypercalcemia, and hyponatremia, are provided. SN - 1527-2729 UR - https://www.unboundmedicine.com/medline/citation/14697157/full_citation DB - PRIME DP - Unbound Medicine ER -

Tags

Management of paraneoplastic syndromes in lung cancer.Curr Treat Options Oncol. 2004 Feb; 5(1):51-62.CT